362 related articles for article (PubMed ID: 11014233)
1. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
Samura A; Wada S; Suda S; Iitaka M; Katayama S
Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
[TBL] [Abstract][Full Text] [Related]
2. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism.
Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1996 Jan; 137(1):312-20. PubMed ID: 8536630
[TBL] [Abstract][Full Text] [Related]
3. Regulation of calcitonin receptor by glucocorticoid in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
Wada S; Yasuda S; Nagai T; Maeda T; Kitahama S; Suda S; Findlay DM; Iitaka M; Katayama S
Endocrinology; 2001 Apr; 142(4):1471-8. PubMed ID: 11250927
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1996 Mar; 137(3):1042-8. PubMed ID: 8603572
[TBL] [Abstract][Full Text] [Related]
5. Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells.
Wada S; Martin TJ; Findlay DM
Endocrinology; 1995 Jun; 136(6):2611-21. PubMed ID: 7750484
[TBL] [Abstract][Full Text] [Related]
6. Homologous regulation of the rat C1a calcitonin receptor (CTR) in nonosteoclastic cells is independent of CTR messenger ribonucleic acid changes and cyclic adenosine 3',5'-monophosphate-dependent protein kinase activation.
Findlay DM; Houssami S; Christopoulos G; Sexton PM
Endocrinology; 1996 Nov; 137(11):4576-85. PubMed ID: 8895320
[TBL] [Abstract][Full Text] [Related]
7. Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts.
Wada S; Udagawa N; Akatsu T; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1997 Feb; 138(2):521-9. PubMed ID: 9002981
[TBL] [Abstract][Full Text] [Related]
8. Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.
Liu BY; Wang JT; Leu JS; Chiang CP; Hsieh CC; Kwan HW
J Formos Med Assoc; 2000 Feb; 99(2):140-50. PubMed ID: 10770029
[TBL] [Abstract][Full Text] [Related]
9. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures.
Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM
J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes.
Yamamoto Y; Yamamoto Y; Udagawa N; Okumura S; Mizoguchi T; Take I; Yamauchi H; Yamauchi H; Noguchi T; Takahashi N
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(3):25-31. PubMed ID: 17535751
[TBL] [Abstract][Full Text] [Related]
11. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
12. [Appropriate clinical usage of calcitonin escape phenomenon and intermittent v.s. daily administration of calcitonin].
Wada S; Yasuda S
Clin Calcium; 2001 Sep; 11(9):1169-75. PubMed ID: 15775628
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin responsiveness and receptor expression in porcine and murine osteoclasts: a comparative study.
Galvin RJ; Bryan P; Venugopalan M; Smith DP; Thomas JE
Bone; 1998 Sep; 23(3):233-40. PubMed ID: 9737345
[TBL] [Abstract][Full Text] [Related]
14. Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA.
Rakopoulos M; Ikegame M; Findlay DM; Martin TJ; Moseley JM
Bone; 1995 Nov; 17(5):447-53. PubMed ID: 8579955
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of the calcitonin receptor by myeloma cells in their osteoclast-like activity in vitro.
Silvestris F; Cafforio P; De Matteo M; Quatraro C; Dammacco F
Leuk Res; 2008 Apr; 32(4):611-23. PubMed ID: 17714780
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin.
Su Y; Chakraborty M; Nathanson MH; Baron R
Endocrinology; 1992 Sep; 131(3):1497-502. PubMed ID: 1324163
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid regulation of calcitonin receptor in mouse osteoclast-like multinucleated cells.
Wada S; Akatsu T; Tamura T; Takahashi N; Suda T; Nagata N
J Bone Miner Res; 1994 Nov; 9(11):1705-12. PubMed ID: 7863821
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms.
Granholm S; Lundberg P; Lerner UH
J Endocrinol; 2007 Dec; 195(3):415-27. PubMed ID: 18000304
[TBL] [Abstract][Full Text] [Related]
19. Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.
Gorn AH; Rudolph SM; Flannery MR; Morton CC; Weremowicz S; Wang TZ; Krane SM; Goldring SR
J Clin Invest; 1995 Jun; 95(6):2680-91. PubMed ID: 7769107
[TBL] [Abstract][Full Text] [Related]
20. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
